PSORIASIS
Active substance: NICKEL SULFATE HEXAHYDRATE, SODIUM BROMIDE, ZINC BROMIDE, POTASSIUM BROMIDE, POTASSIUM SULFATE
LIQUID · NICKEL SULFATE HEXAHYDRATE 3 [hp_X]/237mL, SODIUM BROMIDE 2 [hp_X]/237mL, ZINC BROMIDE 4 [hp_X]/237mL, POTASSIUM BROMIDE 1 [hp_X]/237mL, POTASSIUM SULFATE 4 [hp_X]/237mL
United StatesActive
Marketing holder: PLYMOUTH HEALTHCARE PRODUCTS LLC
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- NICKEL SULFATE HEXAHYDRATE · 3 [hp_X]/237mL
- SODIUM BROMIDE · 2 [hp_X]/237mL
- ZINC BROMIDE · 4 [hp_X]/237mL
- POTASSIUM BROMIDE · 1 [hp_X]/237mL
- POTASSIUM SULFATE · 4 [hp_X]/237mL
Registration
- Registration number
- 61480-105
- Registration status
- Active
- Dispensing
- Over the counter
- Route
- ORAL
Sources
- product · openFDA NDC · 61480-105 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 61480-105 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 61480-105 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 61480-105 · Verified 2026-10-09 · open in source
- ingredients.2 · openFDA NDC · 61480-105 · Verified 2026-10-09 · open in source
- ingredients.3 · openFDA NDC · 61480-105 · Verified 2026-10-09 · open in source
- ingredients.4 · openFDA NDC · 61480-105 · Verified 2026-10-09 · open in source